Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort

European Heart Journal

Volumn 33, Issue 7, 2012, Pages 866-874

  Sliwa, Karen ^a,b,c   Carrington, Melinda J ^b,d   Becker, Anthony ^b   Thienemann, Friedrich ^c,e,f   Ntsekhe, Mpiko ^c   Stewart, Simon ^a,b,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

AIDS; Cardiomyopathy; Cardiovascular disease in Africa; HIV; Pericardial effusion

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOMYOPATHY; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EPIDEMIC; FEMALE; GROUPS BY AGE; HEART DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PERICARDITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SEX DIFFERENCE; SOUTH AFRICA; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOMYOPATHIES; COHORT STUDIES; EPIDEMICS; FEMALE; HEART DISEASES; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SOUTH AFRICA; URBAN HEALTH; YOUNG ADULT;

EID: 84859517742     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr398     Document Type: Article

References (30)

1. United Nations AIDS. UNAIDS report on the global AIDS epidemic. 2010; 364p. http://www.unaids.org/en/ (25 October 2011).
2. Becker AC, Sliwa K, Stewart S, Libhaber E, Essop AR, Zambakides CA, Essop MR. Acute coronary syndromes in treatment-naive black South Africans with human immunodeficiency virus infection. J Interv Cardiol 2010;23:70-77.
3. Khunnawat C, Mukerji S, Havlichek D Jr, Touma R, Abela GS. Cardiovascular manifestations in human immunodeficiency virus-infected patients. Am J Cardiol 2008;102:635-642.
4. Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, Erbel R, Neumann T. Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials 2010;11:156-162.
5. Ntsekhe M, Mayosi BM. Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med 2009;6:120-127.
6. Vedanthan R, Fuster V. Cardiovascular disease in Sub-Saharan Africa: a complex picture demanding a multifaceted response. Nat Clin Pract Cardiovasc Med 2008; 5:516-517.
7. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008;371:915-922. (Pubitemid 351375275)
8. Stewart S, Carrington M, Pretorius S, Methusi P, Sliwa K. Standing at the crossroads between new and historically prevalent heart disease: effects of migration and socio-economic factors in the Heart of Soweto cohort study. Eur Heart J 2011;32:492-499.
9. Stewart S, Libhaber E, Carrington M, Damasceno A, Abbasi H, Hansen C, Wilkinson D, Sliwa K. The clinical consequences and challenges of hypertension in urban-dwelling black Africans: insights from the Heart of Soweto Study. Int J Cardiol 2011;146:22-27.
10. Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, Sliwa K. Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 2008;118:2360-2367.
11. Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, Stewart S. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study. Heart 2010;96: 1878-1882.
12. Stewart S, Wilkinson D, Becker A, Askew D, Ntyintyane L, McMurray JJ, Sliwa K. Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study. Int J Cardiol 2006;108:101-108. (Pubitemid 43324914)
13. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ 2007;85:867-872. (Pubitemid 350086459)
14. Prineas RJ, Harland WR, Janzon L, Kannel W. Recommendations for use of noninvasive methods to detect atherosclerotic peripheral arterial disease - in population studies. American Heart Association Council on Epidemiology. Circulation 1982;65:1561A-1566A.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083. (Pubitemid 9091990)
16. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Tendera M, Auricchio A, Bax J, Bohm M, Corra U, della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zamorano JL, Zannad F. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
17. Becker A, Singh S, Sliwa K, Stewart S, Libhaber E, Essop M. The thrombotic profile of treatment-naïve HIV positive Black South Africans with acute coronary syndromes. Clin Appl Thromb Hemost 2011;17:264-272.
18. Becker A, Sliwa K, Stewart S, Essop M. Markers of inflammation and endothelial activation in black South Africans with HIV and acute coronary syndromes. J AIDS HIV Res 2010;2:95-100.
19. World Health Organization (WHO). Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Revision; 2006. http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf. (16 October 2011).
20. Bijl M, Dieleman JP, Simoons M, van der Ende ME. Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy. J Acquir Immune Defic Syndr 2001;27:318-320. (Pubitemid 32661978)
21. Monsuez JJ, Escaut L, Teicher E, Charniot JC, Vittecoq D. Cytokines in HIV-associated cardiomyopathy. Int J Cardiol 2007;120:150-157. (Pubitemid 47049664)
22. Patel RC, Frishman WH. Cardiac involvement in HIV infection. Med Clin North Am 1996;80:1493-1512. (Pubitemid 26394050)
23. Wu TC, Pizzorno MC, Hayward GS, Willoughby S, Neumann DA, Rose NR, Ansari AA, Beschorner WE, Baughman KL, Herskowitz A. In situ detection ofhuman cytomegalovirus immediate-early gene transcripts within cardiac myocytes of patients with HIV-associated cardiomyopathy. AIDS 1992;6:777-785.
24. Barbaro G. HIV-associated cardiomyopathy etiopathogenesis and clinical aspects. Herz 2005;30:486-492. (Pubitemid 41367140)
25. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010;10: 251-261.
26. Rogers JS, Zakaria S, Thom KA, Flammer KM, Kanno M, Mehra MR. Immune reconstitution inflammatory syndrome and human immunodeficiency virus-associated myocarditis. Mayo Clin Proc 2008;83:1275-1279.
27. South Africa National Department of Health. Clinical Guidelines for the Management of HIV and AIDS in Adults and Adolescents. 2010. http://www. samedical.org/doctors-corner/clinical-guidelines.html. (16 October 2011).
28. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiebaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356: 1723-1735. (Pubitemid 46658704)
29. Mulligan K, Grunfeld C, Tai VW, Algren H, Pang M, Chernoff DN, Lo JC, Schambelan M. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr 2000;23:35-43. (Pubitemid 30123263)
30. Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, Palella F, Visscher B, Evans R, Kingsley LA. Impact of HIV infection and HAART on serum lipids in men. JAMA 2003;289:2978-2982. (Pubitemid 37430100)